Who are Cipros 20 association's main competitors?

Direct comparators (same drug class / molecular target / therapeutic area): moxifloxacin / dexamethasone, Levofloxacin-Amox/clav., ciprofloxacin, cotrimoxazole-trimethoprim, macrodantin, Ciprofloxacin Tablets & Metronidazole tablets, levofloxacin; metronidazole, group-B : Levofloxacin triple therapy.

How often does this brief refresh?

Every 30 minutes from primary sources (FDA, EMA, MHRA, PMDA, ClinicalTrials.gov, USPTO). Subscribe to the RSS feed below for push alerts.

How do I get this as a recurring report?

Subscribe to /feed/ci/cipros-20-association.xml in any RSS reader (Feedly, Inoreader, NewsBlur). Every regulatory action, trial readout, or patent event lands in your feed automatically.

Last reviewed 2026-05-14 · How we verify

Cipros 20 association — Competitive Intelligence Brief

Cipros 20 association (Cipros 20 association) competitive landscape: 6 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Fluoroquinolone antibiotic combination. Area: Infectious Disease.

phase 3 Fluoroquinolone antibiotic combination Bacterial DNA gyrase, topoisomerase IV Infectious Disease Small molecule Live · refreshed every 30 min

Target snapshot

Cipros 20 association (Cipros 20 association) — EMS. Cipros 20 association is a fixed-dose combination of ciprofloxacin and an additional agent designed to enhance antimicrobial efficacy.

Comparator set (6 drugs)

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

Drug	Generic	Sponsor	Phase	Class	Target
Cipros 20 association TARGET	Cipros 20 association	EMS	phase 3	Fluoroquinolone antibiotic combination	Bacterial DNA gyrase, topoisomerase IV
moxifloxacin / dexamethasone	moxifloxacin / dexamethasone	Federal University of São Paulo	marketed	Fluoroquinolone antibiotic + corticosteroid combination	Bacterial DNA gyrase, topoisomerase IV, glucocorticoid receptor
Levofloxacin-Amox/clav.	Levofloxacin-Amox/clav.	Buddhist Tzu Chi General Hospital	marketed	Fluoroquinolone + Beta-lactam/Beta-lactamase inhibitor combination	Bacterial DNA gyrase, topoisomerase IV, penicillin-binding proteins
ciprofloxacin, cotrimoxazole-trimethoprim, macrodantin	ciprofloxacin, cotrimoxazole-trimethoprim, macrodantin	University of British Columbia	marketed	Fluoroquinolone, Sulfonamide-diaminopyrimidine combination, Nitrofuran	Bacterial DNA gyrase, topoisomerase IV, dihydrofolate reductase, bacterial DNA
Ciprofloxacin Tablets & Metronidazole tablets	Ciprofloxacin Tablets & Metronidazole tablets	MinaPharm Pharmaceuticals	marketed	Fluoroquinolone + Nitroimidazole antibiotic combination	Bacterial DNA gyrase, topoisomerase IV (ciprofloxacin); anaerobic DNA (metronidazole)
levofloxacin; metronidazole	levofloxacin; metronidazole	Johnson & Johnson Pharmaceutical Research & Development, L.L.C.	marketed	Fluoroquinolone + Nitroimidazole combination antibiotic	Bacterial DNA gyrase, topoisomerase IV (levofloxacin); bacterial DNA (metronidazole)
group-B : Levofloxacin triple therapy	group-B : Levofloxacin triple therapy	Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh	marketed	Fluoroquinolone antibiotic combination therapy	Bacterial DNA gyrase, topoisomerase IV

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Fluoroquinolone antibiotic combination class)

EMS · 2 drugs in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). Cipros 20 association — Competitive Intelligence Brief. https://druglandscape.com/ci/cipros-20-association. Accessed 2026-05-14.

Build your own brief

Pick any drug + add comparators:

https://druglandscape.com/ci/{slug} — auto-detected competitors
https://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3 — explicit comparators
Brand names auto-resolve: /ci/keytruda → 301 → /ci/pembrolizumab